| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/22/2009 | US20090022746 Complexes for transferring nucleic acids into cells |
| 01/22/2009 | US20090022742 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 01/22/2009 | US20090022729 Methods and compositions for treating cardiac dysfunctions |
| 01/22/2009 | US20090022724 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 01/22/2009 | US20090022703 Treating age-related macular degeneration associated with a loss of elastic fibers by administering a LOXL1 polypeptide that can catalyze the crosslinking of elastin |
| 01/22/2009 | US20090022699 Method Of Genotypically Modifying Cells By Administration Of RNA |
| 01/22/2009 | US20090022683 Biodegradable and Thermosensitive Poly(Organophosphazene) Hydrogel, Preparation Method Thereof and Use Thereof |
| 01/22/2009 | CA2693712A1 Methods and compositions for treating brain diseases |
| 01/21/2009 | EP2017355A1 Gene associated with arteriosclerotic disease, and use thereof |
| 01/21/2009 | EP2017338A1 Muscle-specific expression vectors |
| 01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
| 01/21/2009 | EP2016417A1 Biomarkers for endometrial proliferation |
| 01/21/2009 | EP2015781A2 Compositions having antiangiogenic activity and uses thereof |
| 01/21/2009 | EP1851239B1 Replication-deficient rna viruses as vaccines |
| 01/21/2009 | EP1506228B1 Role of p62 in aging-related disease |
| 01/21/2009 | EP1483375B1 A method for producing recombinant adenovirus viruses using site-specific recombination |
| 01/21/2009 | EP1335973B1 human adenylate cyclase |
| 01/21/2009 | EP1307588B1 Method for diagnosing or determining a risk for psychosis comprising determining an heterozygous mutation of methylenetetrahydrofolate reductase (MTHFR) |
| 01/21/2009 | EP1133316B1 Formulation of adenovirus for gene therapy |
| 01/21/2009 | EP0993468B1 Compositions and methods for activating genes of interest |
| 01/21/2009 | EP0711127B2 Methods of preparing gas-filled liposomes |
| 01/21/2009 | CN101351557A Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein |
| 01/21/2009 | CN101351231A Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 01/21/2009 | CN101351230A Implantable biocompatible immunoisolatory vehicle for delivery of GDNF |
| 01/21/2009 | CN101351229A Therapeutic method for blood coagulation disorder |
| 01/21/2009 | CN101351228A Immune stimulation speciality of compound containing modified immune irritation dinucleotide base on oligonucleotide |
| 01/21/2009 | CN101348799A Construction method and pharmaceutical use of microRNA adenovirus expression plasmid for severe hepatitis related gene hfg12, hFas and hTNFR1 |
| 01/21/2009 | CN101348798A Construction of recombinant adenovirus vector expressing bFGF protein and use of recombinant adenovirus vector for in vivo ear transfection |
| 01/21/2009 | CN101348788A Cell proliferation related gene CNKSR3, screening method and use thereof |
| 01/21/2009 | CN101348787A Preparation and use of giant panda Ascaris schroederi antigen |
| 01/21/2009 | CN101348786A Human ª-globin gene and recombinant adeno related viral vector thereof |
| 01/21/2009 | CN101348512A Antineoplastic ad virus preparation |
| 01/21/2009 | CN101347623A Multifunctional nanodevice platform |
| 01/21/2009 | CN100453647C DNA vaccine carrier of carring SV40 enhancer element |
| 01/20/2009 | USRE40624 An isolated nucleic acid encoding the ASKRK polypeptide comprising an amino acid identification sequence #2; nucleotide sequences; expression vector; pancreatic beta host cell. antidiabetic agents; non-insulin dependent diabetes |
| 01/20/2009 | US7479554 AAV5 nucleic acids |
| 01/20/2009 | US7479552 Type-1 ribosome-inactivating protein |
| 01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
| 01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 01/20/2009 | US7479376 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 01/20/2009 | US7479279 Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders |
| 01/20/2009 | US7479276 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 01/20/2009 | CA2517245C Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |
| 01/20/2009 | CA2236263C Methods for use of mpl ligands with primitive human stem cells |
| 01/19/2009 | CA2605130A1 Vaccine composition and uses thereof |
| 01/15/2009 | WO2009009591A2 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 01/15/2009 | WO2009009441A2 Self-assembling complex for targeting chemical agents to cells |
| 01/15/2009 | WO2009009039A2 Compositions containing full-length l1r nucleic acid and endoplasmic reticulum targeting sequence |
| 01/15/2009 | WO2009008991A2 Dna-pkcs modulates energy regulation and brain function |
| 01/15/2009 | WO2009008990A2 Methods and compositions for treatment of cancer and other angiogenesis - related diseases |
| 01/15/2009 | WO2009008713A1 Tap-inhibitors from old world primate 1-herpesviruses and their use |
| 01/15/2009 | WO2009008511A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
| 01/15/2009 | WO2009008496A1 Anti-hsulf1 antibody |
| 01/15/2009 | WO2009007982A1 A conserved region of the hiv-1 genome and uses thereof |
| 01/15/2009 | WO2009006905A1 Dehydrated chitosan nanoparticles |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008124166A3 Fusion proteins of collagen-binding domain and parathyroid hormone |
| 01/15/2009 | WO2008113983A3 Cancer cell specific promoter comprising nf-kappa b binding sites |
| 01/15/2009 | WO2008103318A3 The adipocyte secreted protein ccdc80 is a potent stimulator of bone formation |
| 01/15/2009 | WO2008097854A4 Method and substances for treating hpv infection |
| 01/15/2009 | WO2008088582A9 Methods and materials related to trail isoforms |
| 01/15/2009 | WO2008085951A3 Treatment of tumors by ablating bone marrow-derived endothelial progenitor cells |
| 01/15/2009 | US20090018321 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090018030 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 01/15/2009 | US20090017559 Methods for diagnosing renal disorders |
| 01/15/2009 | US20090017532 Vector |
| 01/15/2009 | US20090017479 Ly6h gene |
| 01/15/2009 | US20090017103 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017048 Novel Brachyspira hyodysenteriae vaccine |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017018 Uses of mammalian cytokine: related reagents |
| 01/15/2009 | US20090016963 Genes involved in neurodegenerative conditions |
| 01/15/2009 | CA2729923A1 Dehydrated chitosan nanoparticles |
| 01/15/2009 | CA2693646A1 Normal-tension glaucoma model and method for evaluation of test substances by using same |
| 01/15/2009 | CA2692632A1 Methods and compositions for treatment of cancer and other angiogenesis-related diseases |
| 01/15/2009 | CA2690317A1 Replication deficient influenza virus for the expression of heterologous sequences |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014673A1 Tumour-associated peptides which bind to MHC molecules |
| 01/14/2009 | EP2014309A1 Lentiviral vector for exon skipping in a gene encoding a dispensable-domain protein |
| 01/14/2009 | EP2014297A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 01/14/2009 | EP1751289B1 Tc-83-derived alphavirus vectors, particles and methods |
| 01/14/2009 | EP1609858B1 Method for detecting substrates or inhibitors for branched neutral amino acid transporters |
| 01/14/2009 | EP1487486B1 Imidazoquinolineamines as adjuvants in hiv dna vaccination |
| 01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
| 01/14/2009 | EP1331270B1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same |
| 01/14/2009 | EP1278537B1 Compositions for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
| 01/14/2009 | EP1204753B1 Invasive bacteria based viral vaccines |
| 01/14/2009 | EP1183049B1 Modification of biological elements |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP0948614B1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
| 01/14/2009 | CN101346155A Use of MAPC or progeny therefrom to populate lymphohematopoietic tissues |
| 01/14/2009 | CN101342371A Application of LYRM1 gene in preparing medicament for promoting fat cell proliferation |
| 01/14/2009 | CN101342368A Antigenized antibody vaccine for foot-and-mouth disease |
| 01/14/2009 | CN100451115C Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |